Pharmaceutical Technology Europe-03-01-2010

Pharmaceutical Technology Europe

Although efforts have been made to improve solubility, many poorly soluble drugs still reach the market. Peter Nielsen discusses new developments in solubilisation technology, which could help those companies seeking to reinvigorate marketed products.

Special Feature
Pharmaceutical Technology Europe

March 01, 2010

Our digital magazine takes a close look at the challenges and trends of lyophilisation, as well as some of the latest innovations.

Special Feature
Pharmaceutical Technology Europe

March 01, 2010

Freeze drying is widely used in pharmaceuticals to improve the long-term storage stability of labile drugs.

Pharmaceutical Technology Europe

Moisture-activated drying granulation is a simple and effective process for particle size enlargement.

Pharmaceutical Technology Europe
News

March 01, 2010

A round up of some of the news and trends from across the globe.

Special Feature
Pharmaceutical Technology Europe

March 01, 2010

The most important consideration when choosing a freeze dryer is to ensure the system is fit for both today's applications and future needs.

Pharmaceutical Technology Europe
Special Feature

March 01, 2010

Pharmaceutical Technology Europe discusses some of the latest challenges and innovations in pharmaceutical lyophilization.

A new kind of gastro-retentive dosage form for drugs with poor aqueous solubility was developed and evaluated, with the aim of achieving gastro-retention.

Pharmaceutical Technology Europe

March 01, 2010

Last year, a member of the PTE editorial team attended the 2nd Annual Lyophilisation Conference in London (UK).

Pharmaceutical Technology Europe

Could a collaborative approach involving both public and private parties offer a solution to Europe's lack of innovation?

Manufacturing
Pharmaceutical Technology Europe

March 01, 2010

Pharmaceutical Technology Europe spoke with experts about the developments that have shaped the nanotechnology industry today and the benefits that this technology has to offer the pharmaceutical industry, which remain largely untapped.